CC
IDXX icon

Cedar Capital’s Idexx Laboratories IDXX Stock Holding History

Cedar Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,554
Closed -$611K – 112
2020
Q3 		$611K Buy
1,554
+482
+45% +$178K 0.2% 115
2020
Q2 		$354K Buy
1,072
+49
+5% +$14.2K 0.14% 134
2020
Q1 		$248K Sell
1,023
-8
-0.8% -$2.09K 0.12% 139
2019
Q4 		$269K Buy
1,031
+204
+25% +$53.8K 0.12% 155
2019
Q3 		$225K Buy
+827
New +$230K 0.11% 158
2018
Q4 		– Sell
-861
Closed -$215K – 162
2018
Q3 		$215K Buy
+861
New +$209K 0.08% 169

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Cedar Capital's IDXX Position: Q4 2020 in Review

Cedar Capital sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 1,554 shares — an estimated $611K sold.

Cedar Capital first reported a position in IDXX in Q3 2018 and held it in 6 quarters. The position peaked at $611K in Q3 2020. 972 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

  • Cedar Capital reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 1,554 Idexx Laboratories shares in Q4 2020, an estimated $611K.
  • Cedar Capital first reported a position in Idexx Laboratories in Q3 2018 and held it in 6 quarters.
  • Cedar Capital's Idexx Laboratories position peaked at $611K in Q3 2020.
  • 972 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.